When three major Wall Street firms downgrade the same stock on the same day, it demands attention. That’s exactly what happened to Exelon (NASDAQ:EXC | EXC Price Prediction) on April 17, as Barclays, BMO Capital, and Mizuho all cut their ratings simultaneously, each citing a deteriorating regulatory environment.
The immediate trigger was PECO Energy Company’s withdrawal of its electric and gas rate cases filed with the Pennsylvania Public Utility Commission. After filing for a PECO rate increase on March 30 and facing political pushback, the company decided to withdraw its case and focus on operational efficiencies to offset expenses. That single move signaled to analysts the regulatory climate in Pennsylvania.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| EXC | Exelon Corp | Barclays | Downgrade | Overweight | Equal Weight | $50 | $49 |
| EXC | Exelon Corp | BMO Capital | Downgrade | Outperform | Market Perform | $52 | $49 |
| EXC | Exelon Corp | Mizuho | Downgrade | Outperform | Neutral | $51 | $48 |
The Analysts’ Case
Barclays believes Maryland and Pennsylvania are becoming less constructive jurisdictions for Exelon, and that this should result in a wider discount on Exelon’s distribution portfolio on most comparatives. That’s a meaningful concern for a company whose entire business model depends on earning regulated returns across those service territories.
BMO Capital analyst James Thalacker lowered his Exelon stock price target to $49 from $52, citing increased regulatory risk that extends across Exelon’s three primary operating companies. He sees the stock as range-bound over the intermediate term given the lack of a visible path for multiple expansion. Mizuho analyst Anthony Crowdell cut his target to $48 from $51 and views the PECO withdrawal as “an important signal for the degrading regulatory environment in Pennsylvania,” adding that he doesn’t see any near-term catalysts to re-rate the stock.
Company Snapshot
Exelon is one of the largest regulated electric utility companies in the United States, serving customers in Illinois, Pennsylvania, Maryland, Delaware, New Jersey, and Washington D.C. Its subsidiaries include ComEd, PECO, BGE, Pepco, Delmarva Power, and Atlantic City Electric. The company carries a market cap of approximately $47.3 billion and reported full-year 2025 adjusted operating EPS of $2.77, beating its guidance midpoint.
Exelon’s 2026 adjusted operating EPS guidance range of $2.81 to $2.91 signals continued growth, and its $41.3 billion capital plan from 2026 through 2029 reflects ambitious infrastructure investment. The company also pays a quarterly dividend of $0.42 per share, with 5% annual dividend growth targeted through 2029.
What It Means for Your Portfolio
Exelon stock is down roughly 5% year to date heading into this downgrade wave, and shares are trading near $46 as of this writing. All three firms converging on a range-bound outlook with no near-term re-rating catalyst signals a meaningful shift for income investors counting on regulatory tailwinds to drive EXC stock valuations higher.
The fundamentals haven’t collapsed. Exelon’s dividend remains intact, its capital plan is substantial, and its data center load pipeline in northern Illinois is a genuine long-term growth driver.
If you hold Exelon shares for income and stability, the story hasn’t changed overnight, but the regulatory backdrop warrants monitoring. Watch for whether upcoming rate cases in Maryland and Delaware receive favorable outcomes, as those decisions could shift sentiment back toward optimism.
Top Gaining Stocks
Top Losing Stocks